Across two U.K. prospective cohorts, ever-use compared with never-use of oral contraceptives was not linked with a higher ...

A novel molecular imaging agent targeting glypican-3 (GPC3) has demonstrated high sensitivity and specificity in detecting ...

The complex dynamics between liver cancer stem cells (CSCs) and immune cells within the tumor microenvironment (TME) are central to the progression of liver cancer. These interactions are critical ...

An interdisciplinary research team has demonstrated a durable and lasting response to a novel treatment—combined locoregional therapy and immunotherapy (LRT-IO)—for advanced liver cancer patients.

Recommendation 3: The definition of liver cancer oligometastasis (≤5 metastatic/recurrent lesions and ≤2 involved organs) is recommended as the reference criteria for characterizing ...

Biomarker may predict immunotherapy response in liver cancer Date: October 17, 2024 Source: Weill Cornell Medicine Summary: It may soon be possible to determine which patients with a type of liver ...

Dr Subramaniam Ramakrishnan, consultant gastroenterologist at Nuffield Health Chester Hospital, said drinking 12g of alcohol per day increases the risk of liver cancer by 1.1 times. Most read in ...

Liver cancer is a serious disease caused by the abnormal growth of liver cells. This problem often develops slowly, and its early symptoms are so mild that most people ignore them.

Scientists said that cases of the cancer arising from underlying fatty liver disease are on the rise. Stay up to date with notifications from The Independent.

It may soon be possible to determine which patients with a type of liver cancer called hepatocellular carcinoma would benefit from immunotherapy, according to a preclinical study by Weill Cornell ...